Lifeward (LFWD) Income from Continuing Operations (2015 - 2026)
Lifeward (LFWD) reported Income from Continuing Operations of 10793000.0 for Q1 2026, down 123.27% on a YoY basis from 46376321.78 in Q1 2025, and down 101.81% sequentially from 5348000.0 in Q4 2025.
Lifeward (LFWD) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 12 years of Income from Continuing Operations data on file, last reported at 10793000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 123.27% year-over-year to 10793000.0; the trailing twelve-month figure through Mar 2026 stood at 25873000.0 (up 5.92% YoY), and the FY2025 full-year result was 19914000.0, up 31.19% from the prior year.
- Income from Continuing Operations slipped to 10793000.0 in Q1 2026, from 5348000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 3084000.0 in Q3 2024 to a low of 15278000.0 in Q4 2024.
- A 5-year average of 5961823.53 and a median of 5313000.0 in 2022 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 170.93% in 2024 and jumped 65.0% in 2025, its largest moves.
- Tracing LFWD's Income from Continuing Operations over 5 years: stood at 5313000.0 in 2022, then decreased by 6.14% to 5639000.0 in 2023, then plunged by 170.93% to 15278000.0 in 2024, then jumped by 65.0% to 5348000.0 in 2025, then sank by 101.81% to 10793000.0 in 2026.
- Business Quant data shows LFWD's Income from Continuing Operations at 10793000.0 in Q1 2026, 5348000.0 in Q4 2025, and 3170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | -10.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.79 Mn |
| Dec 31, 2025 | -5.35 Mn |
| Sep 30, 2025 | -3.17 Mn |
| Jun 30, 2025 | -6.56 Mn |
| Mar 31, 2025 | -4.83 Mn |
| Dec 31, 2024 | -15.28 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Dec 31, 2023 | -5.64 Mn |
| Sep 30, 2023 | -7.53 Mn |
| Jun 30, 2023 | -4.64 Mn |
| Mar 31, 2023 | -4.32 Mn |
| Dec 31, 2022 | -5.31 Mn |
| Sep 30, 2022 | -5.46 Mn |
| Jun 30, 2022 | -4.45 Mn |
| Mar 31, 2022 | -4.35 Mn |
| Dec 31, 2021 | -3.86 Mn |
| Sep 30, 2021 | -2.68 Mn |
| Jun 30, 2021 | -3.14 Mn |